FT商学院

Inside the ‘killer cell’ factory
利用“杀手细胞”来战胜癌症,是一门好生意吗?

The next stage in the war on cancer may be enlisting patients’ own blood cells to fight the disease
抗癌战争的下一阶段可能是利用患者自身的血细胞来对抗疾病。

Emily Whitehead was diagnosed with acute lymphoblastic leukaemia 14 years ago. The initial prognosis was hopeful, but her treatment did not go well. Emily, who was just five, reacted badly to the standard course of chemotherapy, which caused severe pains in her legs. About two years after her diagnosis, by which time most childhood sufferers are in the clear, the American schoolgirl suffered a relapse. The doctors recommended further intensive bouts of chemotherapy and a bone-marrow transplant, if she was strong enough.

14年前,艾米莉•怀特海德(Emily Whitehead)被诊断出患有急性淋巴细胞白血病。最初的预后是乐观的,但她的治疗并不顺利。年仅五岁的艾米莉对标准化疗反应不佳,导致她的双腿剧痛。确诊大约两年后,大多数儿童患者已经康复,但这位美国小女孩却复发了。医生建议,如果她身体足够强壮,可以进行进一步的强化化疗和骨髓移植。

您已阅读2%(684字),剩余98%(27274字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归manbetx20客户端下载 所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×